Patients’ Experience and Perception of Hospital-Treated Clostridium difficile Infections: a Qualitative Study-Reference-Cited by-同舟云学术

Patients’ Experience and Perception of Hospital-Treated Clostridium difficile Infections: a Qualitative Study

Published:2014-01-09 Issue:1 Volume:7 Page:97-105
ISSN:1178-1653
Container-title:The Patient - Patient-Centered Outcomes Research
language:en
Short-container-title:Patient

Author:

Guillemin Isabelle,Marrel Alexia,Lambert Jérémy,Beriot-Mathiot Axelle,Doucet Carole,Kazoglou Odysseas,Luxemburger Christine,Reygrobellet Camille,Arnould Benoit

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1007/s40271-013-0043-y.pdf

Reference26 articles.

1. Viscidi R, Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology. 1981;81(1):5–9.

2. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009;7(7):526–36.

3. Cohen SH, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55.

4. Bauer MP, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377(9759):63–73.

5. Lucado J, Gould C, Elixhauser A. Clostridium difficile infections (CDI) in hospital stays, 2009: HCUP statistical brief #124. Agency for Healthcare Research and Quality; 2012.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking the Cycle of Recurrent Clostridioides difficile Infections: A Narrative Review Exploring Current and Novel Therapeutic Strategies;Journal of Pharmacy Practice;2024-05-13

2. Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the Details;Infection and Drug Resistance;2024-02

3. Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile Infection;Infectious Diseases and Therapy;2024-01

4. Effect of Fecal Microbiota, Live-Jslm (REBYOTA [RBL]) on Health-Related Quality of Life in Patients With Recurrent Clostridioides difficile Infection: Results From the PUNCH CD3 Clinical Trial;Open Forum Infectious Diseases;2023-07-20

5. Patient Experiences with Clostridioides difficile Infection and Its Treatment: A Systematic Literature Review;Infectious Diseases and Therapy;2023-07